Keros Therapeutics (KROS) Return on Assets (2020 - 2025)

Keros Therapeutics (KROS) has 6 years of Return on Assets data on file, last reported at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Assets changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, up 1.0% from the prior year.
• Return on Assets for Q4 2025 stood at 0.0%, up from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q4 2025 and bottomed at 0.0% in Q4 2023.
• The 5-year median for Return on Assets is 0.0% (2022), against an average of 0.0%.
• Peak annual rise in Return on Assets reached 0 bps in 2021, while the deepest fall reached 0 bps in 2021.
• A 5-year view of Return on Assets shows it stood at 0.0% in 2021, then sank by 55 bps to 0.0% in 2022, then sank by 30 bps to 0.0% in 2023, then soared by 36 bps to 0.0% in 2024, then soared by 151 bps to 0.0% in 2025.
• The last three Return on Assets figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.

Peer Comparison